Senaptec is a leader in sensory performance, specializing in assessing and improving an individual’s vision skills. The company's flagship product, the Senaptec Sensory Station, utilizes software to analyze an individual on 10 fundamental skills related to their vision and motor response, comparing the results to Senaptec’s proprietary sensory database. Following assessment, Senaptec offers training/therapy software to improve the skills with the greatest opportunity, which runs on the Sensory Station and individual tablets for at-home training. Additionally, Senaptec manufactures the Strobe Eyewear, designed to provide resistance training for the brain by utilizing liquid crystal technology to flicker between clear and opaque lenses, forcing the individual to process visual information more efficiently.
Founded in 2013 and headquartered in the United States, Senaptec operates in the biotechnology and health care industries. The company recently secured a $924.32K in a Venture Round investment on 15 February 2022.
Senaptec’s focus on sensory performance and its innovative tools for vision skill assessment and improvement position it at the intersection of sports performance, rehabilitation, and general brain health. The recent investment underlines the growing interest in the company's unique approach and signifies potential for scalability and further development within the market.
No recent news or press coverage available for Senaptec.